On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Advances in Oncology and Radiotherapy

TopicLeading institutions, researchers & key papers

Advances in Oncology and Radiotherapy is a topic indexed in ScholarIQ from OpenAlex.

What is known about Advances in Oncology and Radiotherapy?

ScholarIQrecord summary

This cluster of papers focuses on the global access to radiotherapy, including its role in cancer treatment, the expansion of access in low- and middle-income countries, workforce analysis, health economics, and infrastructure assessment. The papers also address the demand estimation for radiotherapy, medical education in oncology, and resource planning for optimal utilization.

How many works does Advances in Oncology and Radiotherapy have?

ScholarIQindexed works

Advances in Oncology and Radiotherapy has 79 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Advances in Oncology and Radiotherapy?

ScholarIQopenalex

The OpenAlex for Advances in Oncology and Radiotherapy is on the source record.

What are the most-cited papers on Advances in Oncology and Radiotherapy?

ScholarIQmost cited works
Gender Differences in Publication Productivity, Academic Position, Career Duration, and Funding Among U.S. Academic Radiation Oncology Faculty
Emma B. Holliday, Reshma Jagsi, Lynn D. Wilson, Mehee Choi, Charles R. Thomas, Clifton D. Fuller
Academic Medicine. 2014204 Citations
Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments
Stuart McIntosh, Fareeha Alam, Laura E. Adams, Ian S. Boon, J. Callaghan, Isabella Conti, Ellen Copson, Victoria Carson, Mitchell Davidson, Helen Fitzgerald, Ashram Gautam, Christopher M. Jones, S A S Kargbo, Gokul R Lakshmipathy, Hannah Maguire, Kathryn McFerran, Amatta Mirandari, Natasha Moore, Ross Moore, Aidan Murray, Lydia Newman, Stephen Robinson, Ashvina Segaran, Chin Nam Soong, Andrew A. Walker, Kusal Wijayaweera, Rifat Atun, Ramsey Cutress, Michael Head
The Lancet Oncology. 2023123 CitationsOPEN ACCESS
American Association of Physicists in Medicine (AAPM)
Brian F. Hasson, Charlie Ma, Lu Wang, David E. Wazer, Jay E. Reiff, Jay E. Reiff, Brandon J. Fisher, Tod W. Speer, James H. Brashears, John P. Christodouleas, Anthony E. Dragun, Volker Budach, Timothy Holmes, Filip T. Troicki, Jaganmohan Poli, Filip T. Troicki, Jaganmohan Poli, Lindsay G. Jensen, Loren K. Mell, Stephan Mose, Erik Limbergen, Cheng B. Saw, Nisha R. Patel, Michael L. Wong, Ning J. Yue, James H. Brashears, Curt Heese, Ramesh Rengan, Charles R. Thomas, Rene Rubin, Rene Rubin, Jay E. Reiff, Jay E. Reiff, Nisha R. Patel, Michael Wong, Jo Ann Chalal, Gerhard G. Grabenbauer, Lindsay G. Jensen, Brent S. Rose, Arno J. Mundt, Ning J. Yue, Rene Rubin, Tod W. Speer, Tod W. Speer, Rene Rubin, Rene Rubin, Rene Rubin, Tod W. Speer, Daniel J. Indelicato, Robert H. Sagerman, Lydia T. Komarnicky-Kocher, Christin A. Knowlton, Michelle Kolton Mackay, Jo Ann Chalal, Darek Michalski, M. Saiful Huq
2012110 Citations
Evaluating Travel Distance to Radiation Facilities Among Rural and Urban Breast Cancer Patients in the Medicare Population
Colleen Longacre, Hannah T. Neprash, Nathan D. Shippee, Todd M. Tuttle, Beth A Virnig
The Journal of Rural Health. 201960 Citations
Evaluation of Internet-based oncologic teaching for medical students.
Minesh P. Mehta, Prashant Sinha, K Kanwar, Amber Anne Inman, Maria Albanese, William E. Fahl
PubMed. 199847 Citations

Where is Advances in Oncology and Radiotherapy research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Advances in Oncology and Radiotherapy is open access?

ScholarIQopen access share
44%OPEN ACCESS
Gold
11%
Green
22%
Hybrid
11%
Bronze
0%
Closed
56%

Related on ScholarIQ

470M+ articles · 14-day free trial